Mesothelioma.com Resources for Patients and their Families

Mesothelioma News

News Icon

News from the United States and around the world on topics related to mesothelioma and asbestos. Please email us at info@mesothelioma.com if you have a news story you would like us to report on.

Could Keytruda and Chemotherapy Become New Standard of Care for Mesothelioma?

Researchers announce Keytruda and chemotherapy as the new standard of care for metastatic NSCLC, which could impact mesothelioma. Learn more at Mesothelioma.com.

Using Tumor Treating Fields with Chemotherapy to Treat Pleural Mesothelioma

A clinical trial is testing the efficacy of Tumor Treating electron fields with chemotherapy for pleural mesothelioma. Learn more at Mesothelioma.com.

New Flowchart Could Help Diagnose Pleural Mesothelioma Faster

A new flowchart developed by Tunisian researchers could help doctors diagnose pleural mesothelioma faster, giving patients a better chance of survival.

Johnson & Johnson and Rite Aid Face Asbestos Talcum Powder Lawsuit

Johnson & Johnson and Rite Aid were named as defendants in a lawsuit alleging baby powder led to a woman’s mesothelioma. Read more at Mesothelioma.com.

Researchers Discover New Marker to Detect Epithelioid Mesothelioma

A new clinical trial observed a novel immunohistochemical marker that can differentiate epithelioid mesothelioma from lung adenocarcinoma. Learn more at Mesothelioma.com.

Clinical Trial Tests Novel Chemotherapy Treatment on Peritoneal Mesothelioma Patients

European researchers are testing an aerosol chemotherapy treatment called PIPAC on peritoneal mesothelioma patients. Learn more about the novel study at Mesothelioma.com.

USGS Develops Asbestos Detection Tool for Vermiculite Insulation

Since much of the vermiculite insulation produced from Libby, Montana, contains dangerous asbestos, USGS scientists created a new tool to better detect the toxin. Learn more at Mesothelioma.com.

Combination Immunotherapy Treatment Looks Promising for Mesothelioma

Researchers at Massachusetts General Hospital have discovered a promising combination immunotherapy treatment for mesothelioma. Learn about the clinical trial at Mesothelioma.com.

Johnson & Johnson Faces $117 Million Verdict in First Asbestos Talcum Powder Lawsuit Loss

New Jersey jury found Johnson & Johnson guilty in first asbestos talcum powder lawsuit loss, resulting in a $117 million verdict. Read about the case at Mesothelioma.com.

Johnson & Johnson Loses First Asbestos Talcum Powder Lawsuit

Johnson & Johnson lost its first asbestos talcum powder lawsuit with a $37 million verdict. Read about the case at Mesothelioma.com.

Next >

Resources for Mesothelioma Patients and Their Families

Search the News:

Search the News

Upcoming Events

September 2018

ADAO Mesothelioma Awareness Month

“The Asbestos Disease Awareness Organization's (ADAO) mission is to educate the public and medical community about asbestos-related diseases and preventing asbestos exposure, while supporting research that leads to early detection, prevention, and a cure. For more information, please visit the organization's website via the link below. ”


9/8/2018
Starting point: Admiral’s Marina, Stillwater, NY

Kayaking for Meso

“Kayaking for Meso’s mission is to raise awareness about asbestos-caused mesothelioma and to raise money for research to fight this rare cancer. Monies raised will be donated to the Mesothelioma Applied Research Foundation (MARF). For more information, please visit Kayaking for Meso's website via the link below. ”